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Abstract 
 
Community engagement in research, including public health related research, is acknowledged 
as an ethical imperative. While medical care and public health action take priority over research 
during infectious disease outbreaks, research is still required in order to learn from epidemic 
responses. The World Health Organisation developed a guide for community engagement during 
infectious disease epidemics called the Good Participatory Practice for Trials of Emerging (and 
Re‐emerging) Pathogens that are Likely to Cause Severe Outbreaks in the Near Future and for 
which Few or No Medical Counter‐Measures Exist (GPP‐EP). This paper identified priorities for 
community engagement for research conducted during infectious disease outbreaks drawing on 
discussions held with a purposive sample of bioethicists, social scientists, researchers, policy 
makers and laypersons who work with ethics committees in West Africa. These perspectives 
were considered in the light of the GPP‐EP, which adds further depth and dimension to 
discussions on community engagement frameworks. It concludes that there is no presumptive 
justification for the exclusion of communities in the design, implementation and monitoring of 
clinical trials conducted during an infectious disease outbreak. Engagement that facilitates 
collaboration rather than partnership between researchers and the community during epidemics is 
acceptable. 
 
1 Introduction 
 
Miller et al1 argued that community engagement in research, including public health related 
research, is an ethical imperative because both the conduct and the outcomes of research can 
have significant impacts on communities. Research and research outcomes should not be 
imposed on people without providing the opportunity for communities to collaborate and 
determine the goals, structures and processes of proposed research. Such engagement helps to 
address the complex inter‐relationships between the biological dimension and consequences of 
the diseases and their social, cultural and political dimensions2 in ways that can promote health 
and well‐being. 
 
 During infectious disease outbreaks, medical care and public health action generally take 
priority over research. However, this prioritisation does not imply research is unimportant during 
epidemics. Research is critical for generating information that may enable current or future 
outbreaks to be better controlled and thus reduce human suffering. One of the lessons from 
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human rights‐based public health is that research should not displace measures that directly 
address care needs and curtailment of ongoing transmission for both humanitarian and pragmatic 
reasons, because it instrumentalises people when they are at their most vulnerable, and because 
the cooperation of communities in epidemic control depends on their interests being recognised 
and respected.3 
 
 In the outbreak context, research has often been packaged with both medical care and 
public health action. In some documented instances4 research conducted during epidemics has 
not adhered to foundational requirements such as informed consent and ethical review, let alone 
more demanding standards such as community engagement.5 The development by the World 
Health Organisation (WHO) of a document that outlines the responsibility to include community 
engagement in research conducted during an infectious disease outbreak is thus an important 
step. The WHO document, which has the descriptive title ‘Good Participatory Practice for Trials 
of Emerging (and Re‐emerging) Pathogens that are Likely to Cause Severe Outbreaks in the 
Near Future and for which Few or No Medical Counter‐Measures Exist’, or GPP‐EP for short, 
cements the centrality of community engagement even when there are many potentially 
conflicting priorities.6 
 
 This paper will consider priorities for community engagement for research conducted 
during an infectious disease outbreak drawing on discussions held with a purposive sample of 
bioethicists, social scientists, researchers, policy makers, and laypersons. These include persons 
that work in the field in West Africa, those who work with ethics committees in West Africa, and 
experts who work on cross‐cutting bioethics and community engagement issues in and outside 
West Africa and at a global level. We have focused on West Africa for a number of reasons. 
First, the sub‐region has very low capacity for research conduct. The implication is that, for the 
near future, most critical health crisis research responses will be initiated by partners from the 
North. Second, the community in West Africa is largely communitarian in practice. This has 
significant implications for research conduct as highlighted by Folayan and Haire.7 The 
perspectives shared will be considered in the light of the GPP‐EP, which will add further depth 
and dimension to discussions on community engagement frameworks. 
 
2 Background 
 
One of the lessons learned from the conduct of HIV research is that community engagement 
enhances the quality of research and promotes a sense of joint ownership by both researchers and 
community members.8 This in turn promotes community support for the research process that 
can translate to timely recruitment of study participants, improved informed consent and 
enhanced uptake and use of research outcomes (knowledge and skills) irrespective of what the 
results of the research may be.9 Generally, the belief is that communities are thereby left better 
off at the end of the research, and research capacity is strengthened by the efficiencies created in 
collaborative processes. 
 
 Predating GPP‐EP, a set of guidelines known as the “Good Participatory Practice (GPP) 
guidelines for [stakeholder engagement in] biomedical HIV prevention trials” were developed by 
UNAIDS and AVAC. GPP stipulate some minimum requirements for community engagement in 
biomedical HIV prevention research10 many of which are applicable beyond the HIV prevention 
research field. The GPP counsel that researchers engaged in HIV prevention research can 
improve the outcomes and uptake of their work through the conduct of—among other things—
formative research. Formative research will help the study identify and understand nuances about 
the community and relevant stakeholders that should inform the development of stakeholder 
engagement plans, stakeholder advisory mechanisms, communication plans, stakeholder 
education plans, and unforeseen or unexpected issues management plans. 
 
 While the GPP is a useful guide in planning and conducting many HIV prevention 
clinical trials,11 the applicability of these principles during the conduct of a public health 
emergency of the nature witnessed during the 2013 to 2015 West Africa Ebola epidemic is 
unknown. The West Africa Ebola epidemic resulted in an underestimated 28,616 suspected cases 
and 11,310 (39.5%) deaths in Guinea, Liberia, Nigeria and Sierra Leone.12 The outbreak spread 
to Mali, Senegal, United Kingdom and Italy. There were secondary infection of medical workers 
in the United States and Spain.13 This was the 25th outbreak of Ebola since its discovery in 
1976.14 
 
 In the absence of a preventive or curative therapy for Ebola; and in view of the 
biosecurity threat that Ebola poised, a few treatment and vaccine trials were initiated in the 
countries worst affected by the epidemic.15 In such a situation, the urgent need for action may be 
considered a higher priority than a (potentially time consuming) collaborative community 
engagement processes. Nevertheless, even in an emergency context, cooperation between local 
citizens, public health authorities, providers of medical services and researchers is required to 
minimise friction and conflict between these actors. 
 
 Emergency infectious disease outbreaks usually require swift action to address morbidity 
and mortality and limit ongoing infection. Where an epidemic has the potential to run its course, 
there is usually a need to fast‐track essential research data collection processes. Despite the 
urgency involved in an emergency outbreak response, it is expected that the ethical principles 
that have been pivotal in the conduct of ethical biomedicine research – autonomy, beneficence, 
non‐maleficence, justice16 – will apply. Of note, however, there may be tensions between the 
frameworks that govern research ethics, which emphasises the individual, and those that govern 
public health, which include concepts of health maximisation, transparency and 
proportionality.17 Considerations for humanitarian ethics that promotes humanity, neutrality, 
impartiality and independence, also introduces additional conflicts and complexities in decision‐
making.18 Where urgent decisions need to be taken, ethical trade‐offs may be required some of 
which may imply that actions are taken that preclude transparency, neutrality and 
inclusiveness.19 There is little clarity however, about how to negotiate the ethical terrain when 
principles come into conflict during such an emergency. 
 
 There is a substantial body of work discussing perspectives, propositions and case studies 
on models for community engagement during clinical trials that are conducted in non‐outbreak 
conditions. Until a new version of the GPP adapted specifically for use in emergency infectious 
diseases outbreaks (the GPP‐EP) was developed by the WHO,20 there was scant literature on 
how to balance conflicting demands regarding community engagement during an infectious 
disease outbreak. The GPP‐ED proposes that effort be made to foster respect between the 
research team, the community and its representatives, ensure parties negotiate and achieve clear 
understanding of diverse roles and responsibilities, establish community engagement 
mechanisms that are independent of the research systems and structures, and hold open and 
honest communication in a clear, comprehensible and timely fashion. 
 
 While the GPP‐EP was published after the West African Ebola outbreak, the principles 
articulated within it are not novel – the innovation lies in the consideration of how these apply 
under emergency conditions. The GPP‐EP also provides a tool with which to analyse the clinical 
research that was conducted during the West African Ebola outbreak, not to measure compliance 
(as the GPP‐EP was not published), but to test the extent to which norms articulated in the GPP‐
EP were normative practices during the outbreak. The question that arises is whether the GPP‐EP 
provides a sufficient framework for community engagement practices in research during 
emergencies, or whether further articulation and refinement is likely to be necessary. 
 
 Given the magnitude and scale of recent infectious disease outbreaks and the need to 
conduct clinical trials to develop therapies and vaccines for infectious diseases with a propensity 
to cause Ebola‐like epidemics, we identified a need to distil further recommendations about 
community engagement programmes in outbreak research. A starting point is to develop a model 
for community engagement in research that can be applied during an emergency infectious 
disease outbreak.21 We aim to present elements of a community engagement framework that 
may be applicable for the West African region. We shall also be focusing on community 
engagement during clinical trials rather than during social and behavioural science research as 
clinical trials may be more disruptive to the routine norms and social values of communitarian 
societies found in West Africa that protects collectivism22 than individualism otherwise 
promoted during clinical trials. Critical considerations for community engagement during 
clinical trials is therefore needed. 
 
3 Methodology 
 
In order to develop this model, we considered the following four research questions: 1) what 
should the objectives of community engagement during infectious disease epidemics be; 2) how 
should community engagement be conducted during an infectious disease epidemic of the nature 
like Ebola; 3) how should the histories, politics and the socio‐cultural context of communities 
inform the design and implementation of such research; and 4) when is the omission of 
community engagement acceptable for clinical trials conducted in an emergency situation? 
 
 The Delphi process was adapted for the process of answering these questions, drawing on 
the views of stakeholders with experience in research ethics, clinical trials and the West African 
Ebola outbreak. Multiple iterations of views were considered until consensus was achieved.23 
Figure 1 below is a diagrammatic representation of the iteration process. Data were generated 
through four study phases involving consultative meetings with various groups of experts for the 
purpose of validating results generated prior consultations. 
 
  
Figure 1: Flow diagram of the consensus reaching process for the consultations using Delphi 
method 
 
 
 
Phase I:  
 
This phase was made of two rounds of consultation with experts 
 
Round 1:  
 
Following an online survey that collected initial perspectives from the participants, we conducted 
a two day face‐to‐face discussion with experts in the fields of ethics and community engagement 
on 14th‐15th December 2016 in Abuja, Nigeria. They all had experience in both disciplines. The 
meeting brought eight experts together: four from Nigeria, two from Liberia and one person from 
Canada and Australia respectively. The meeting sought to answer the four research questions 
over a series of six meeting sessions. These began with a discussion of the online survey, 
followed by iterative process of eliminating areas of contention until consensus was reached. 
 
 At the end of each day's meeting, a daily assessment was conducted to enable participants 
share other perspectives and opinions on the topics discussed. This was an additional avenue to 
harness further thoughts and ideas not shared during the consultative meeting. These ideas and 
concepts were pooled into the report of the meeting outcomes. 
 
Round 2:  
 
Nine months later, between 12th and 19th of August 2017, the summary document based on the 
outcome of the discussions in round 1 was shared with eight experts engaged in face to face 
meeting in round 1. In addition, three new experts from Nigeria (bioethicist), Sierra Leone 
(clinical trialist involved with Ebola trial) and Kenya (expert on community engagement issues) 
were invited to share comments on the document. Comments were shared via email and a 
summary document was produced. Areas of disagreement and agreement were identified. After 
further exploration of views, issues on which there was disagreement were dropped. 
 
Phase II:  
 
Between the 24th of August and 4th of September 2017. The Phase II process conducted in two 
rounds. 
 
Round 1:  
 
The consensus document developed from Phase I was shared with three new experts via email: a 
bioethicist, a clinical trialist involved with Ebola epidemic in West Africa, and a seasoned 
researcher on community engagement issues. This new group reviewed the consensus document 
and provided comments. A consensus document was developed from this round of discussions. 
 
Round 2:  
 
The consensus document developed from the Phase II round I was shared with the eight of the 11 
experts (three made no contributions to the discussion despite several promptings. The three 
experts were from Nigeria) engaged in Phase I and the three experts engaged in the Phase II. 
They were required to review the document, make comments, inputs and issue clarifications. The 
final document developed from the Phase II round 2 process only contained consensus 
statements reached by this panel. 
 
Phase III:  
 
From the 25th to 27th of September, 2017, 20 persons – bioethicists, social scientists, 
researchers, policy makers and laypersons – who work with ethics committee in West Africa and 
met in Senegal and discussed the consensus statements reached by the panel of experts through 
group works. This phase included two of the eight experts involved in the round 1. The aim of 
this review process was to validate the consensus statements. The review of this document was 
expected to be grounded in the lived experiences of this group of reviewers. The reviewers 
studied the consensus document, and discussed the statements initially during group work and 
then during a plenary session. The output of the validation process was a consensus document 
statement containing only statements agreed to by participants. 
 
Phase IV:  
 
The final phase of the process was the review of the consensus document by three new experts in 
the field of bioethics and community engagement in clinical trials and research. These experts 
had worked in the field for several years, and had been involved with the development of 
international guidelines on bioethics and community engagement in research. These experts 
reviewed the validated consensus document. They focused on establishing ethical justifications 
for the consensus statements. Statements that could not be substantiated with an ethical rationale 
were dropped from the consensus statements. 
 
Ethical considerations: 
 
Ethics approval for the study was obtained from the Institute of Public Health, Obafemi 
Awolowo University, Ile‐Ife, Nigeria (IPHOAU/12/700). 
 
4 Outcomes of Deliberations 
 
What should the objective of community engagement during clinical trials conducted during 
infectious disease emergencies be? 
 
1. Relationship building for the purpose of facilitating the successful implementation of the 
research by enhancing public health education, promoting collaboration and dispelling 
unfounded fear and rumours is a key objective. 
2. Research should be locally responsive – research aims and processes should serve the 
interests of people locally and not be merely ‘acceptable’. 
3. Community engagement should build in‐depth understanding of how research processes 
are likely to work out in practice in a given setting, maximize benefits and minimize 
costs/burdens to participants and communities. 
4. Community engagement should strengthen scientific outcomes by making sure that 
research tools are appropriate; and the implementation process will likely result in 
collection of valid information. 
5. Priorities of researchers and community advocates might differ: for advocates, the critical 
role is protecting the rights and integrity of the citizenry, including ensuring the research 
addresses its needs. For researchers, critical goals are to ensure success and minimize 
challenges, misconceptions and the fueling of rumours able to jeopardize research. 
 
 Ideally, the goal of community engagement should be threefold: to increase the validity 
of research; improve research measures, interpretations, and knowledge translation and 
dissemination; and provide a platform for vulnerable and excluded communities to be included 
in decision‐making about the research.24 Doing so can facilitates joint researcher and 
community ownership of the research; and stimulates community members’ interest as they are 
empowered by their own home‐grown efforts/contributions to address the peculiar health related 
challenges affecting their community. This also can help to promote sustainability of the 
community response, improve the research outcome, and minimize rivalry for leadership 
positions within the research enterprise by community members. The ultimate goal of 
community engagement is to ensure that the research is responsive to the needs of the 
community, and the research methods and processes are acceptable to them. 
 
 During the consultative meetings, participants argued that these benefits of community 
engagement were laudable but some goals may be considered utopian and aspirational for off‐
shored clinical trials conducted during infectious disease emergencies in communities where 
research literacy is low. Even when ideal goals of community engagement are not achievable, at 
the least, researcher should implement a structured community engagement plan that can be 
monitored for its impact. Researchers should also acknowledge community members as 
essential, strategic, and uniquely knowledgeable and skilled actor25 in the research enterprise. 
This requires that space be created for the two parties – researchers and communities ‐ to 
collaborate and exchange ideas with the intention that the outcomes of these deliberations can 
improve the outputs of science. 
 
 Participants in the consultative meetings recognized that models developed for 
community engagement aimed at democratising science and liberalising its paternalistic 
tendencies. Models that focused on advancing social equity, inclusion and well‐being may 
struggle to be implemented in an epidemic of an emergency nature like that seen during the West 
Africa Ebola epidemic; and in societies where respects for rights of persons are not 
institutionalized as is the case with many countries in West Africa. Participants recognized also 
that while rights of communities are limited by the laws that govern public health response, there 
are no laws that limit the scope of a community engagement plan conducted for any research. 
Efforts supportive of research implementation – inclusive of the community engagement process 
‐ should nevertheless, not distract from the public health response instituted to contain an 
emergency epidemic outbreak, nor from associated medical care and public safety. 
 
How should community engagement be conducted during an infectious disease epidemic in West 
Africa? 
 
1. Community engagement should occur through a collaborative model that actively 
involves community stakeholders in discussions and deliberations on the implementation 
of the research in ways that ensures transparency and accountability. 
2. Community engagement process should be guided by a context‐specific community 
engagement plan developed in consultation with political leaders and community 
members. 
3. The key value that should underpin community engagement processes during research 
implementation is respect: respect for community values and the competency all parties 
bring to the deliberations. 
4. The implementation of the community engagement plans should be fast‐tracked. 
Community emergencies identified in the course of the implementation of the plan should 
be resolved through notification of appropriate agencies in charge of managing the 
emergency. 
 
 Model of engagement should be collaborative: Participants at the consultative meetings 
felt that a useful model for community engagement for clinical trials to be conducted in an 
infectious disease epidemic outbreak context, is one that facilitates collaboration between 
researchers and the community rather than one that promotes partnership. The distinction may be 
small, yet important. Partnership requires that the research activities are responsive to the needs 
of the host community allowing for communities to have a say in the design and implementation 
of the research26 whereas collaboration provides a mechanism for consultation and dialogue 
between researchers and community members that contributes to protecting communities and 
fostering meaningful research.27 
  Values that should underpin the engagement process: Respect was a key value identified 
as critical to a community engagement process. Ethics committee members reviewing research 
protocols can help ensure protocols reflect this value. Engagement of researchers with trusted 
community members/ political, security, religious and cultural gatekeepers is a demonstration of 
respect. Respect is also demonstrated by adopting existing community communication structures 
to facilitate open bi‐directional dialogues. Participants at the consultative meetings recognized 
that equity during dialogues may be challenging. It can however be achieved through 
acknowledgement of each party's (researchers and community members) competency and 
equality; and recognising the contribution each can make for successful research outcomes. 
 
 Recognition of competencies: Both researchers and community members have important 
skills and competencies. Researchers will be science literate and highly competent in thinking 
through how generated data can be translated to useful information that can improve the course 
and change the negative trajectory of an infectious disease epidemic. On the other hand, 
community members are community literate and can provide information that will facilitate the 
generation of data about disease transmission and its dynamics, in a timely manner. Together, 
researchers and community members can identify the issues; collect, analyze and interpret the 
data; and decide how to use the results to inform policy, change practice and improve conditions 
in the community.28 
 
 Develop a community engagement plan: It is reasonable to develop context‐specific ‘best 
practices’ on community engagement for specific research goals as opposed to the proposal by 
Pedi et al29 for a set of global standards for meaningful community engagement. Context‐
specific community engagement programmes (outlined in a developed community engagement 
plan) should be grounded in the social practices and norms of the community thereby allowing 
for prompt identification and response to community specific issues that may otherwise impede 
or delay the engagement process. It also helps to foreground the interplay between community 
dynamics, local understanding of the disease and cultural practices around care seeking, and 
dealing with illness and death.30 Conducting formative research prior to research 
implementation will help identify the social norms, practices and values that can influence the 
research process and how to address them effectively. The plan should include activities on 
advocacy, media engagement, external communications and community mobilization related 
issues. 
 
 Knowledgeable community members and survivors of diseases being investigated should 
be sought and engaged as community representatives. It will not always be easy to identify 
community members who have a) the requisite technical experience to give advice on research; 
b) the close understandings and connections with community to reflect the views and values of 
the wider community; and, c) the integrity and reputation to be able to serve as community a 
representative. Given this challenge, community accountability—how the wider community can 
come to know who is taking on the role of community representatives, and how they are 
fulfilling it—is an issue to be resolved. 
 
 Fast‐track context‐specific community engagement process: This will also help shorten 
the time for implementing the community engagement process. In effect, though the GPP‐EP 
should be adapted to the local context, the breadth and depth of the community engagement 
programme should not compromise on the breadth and depth of the requirement of the GPP‐EP. 
This implies that rather than engage community with pre‐protocol development activities, the 
community may be engaged to critique and amend the protocol. However, when protocols are 
developed ahead of an outbreak (generic/pre‐review protocols), the community engagement 
process should follow the requirements of the GPP – community members should be involved 
with research conceptualisation and design. 
 
 Engage political leaders: National and local community leaders should be engaged first 
prior to engagement of community members. The process might include meeting with national 
and local leadership, religious and traditional leaders, community health practitioners, 
community based organizations as well as community advocacy groups. This can help to create 
the needed political will and promote a conducive environment for the research. Engagement 
with political leadership should not however subsume the goal of engaging local community 
members. Also, the political expediency to conduct research during outbreaks, and political 
support for any research should not result in omission of engagement with community members. 
 
 Consultation participants also acknowledged that political leaders can exercise power in 
perverse ways that researchers may not want to support. It is therefore important to identify 
multiple channels through which to engage with community members rather than relying solely 
on a political leader as portal of entry to the community. 
 
 Resolve emergency community needs that may impact research negatively: Where there 
are emerging community needs identified through a community consultative process that may 
affect disease control, researchers would appear to have a moral obligation to help the 
community resolve the emergency needs. These needs do not have to be addressed through direct 
funding from the research. Researchers can link the community to appropriate institutions in the 
position to address those needs. Consultation participants recognized that these needs are often 
complex and deep‐seated; and are related to cultural and socio‐political structures like gendered 
power or economic inequities that realistically researchers will not be able to resolve. Some of 
the needs may be ameliorated by facilitating referrals or providing technical support for effecting 
change. 
 
What are the considerations for research design and implementation during an infectious 
disease epidemic? 
 
Formative research should be implemented. This should inform the design and 
implementation of the main study and the development of the community engagement 
plan. 
 
 Formative research can be conducted prior to the design of the research implementation 
plan, using a participatory approach to identify considerations for research design and 
implementation during an infectious disease epidemic. Formative research can highlight 
historical, social and political concerns that can influence community participation in research. It 
can also generate information about the concerns of vulnerable community members and how 
their needs could be addressed while implementing the research. Vulnerability is a contextual 
concept and should be qualified by an understanding of what the person is vulnerable to and 
why.31 In many low resource settings in West Africa, almost everyone in a remote rural setting 
will be vulnerable to poor health care access. Formative research helps define the situation on the 
ground and generate evidences to support decision‐making about research design and 
implementation.32 
 
How should the history, political and socio‐cultural context of communities inform the design 
and implementation of clinical trials conducted during infectious disease emergencies in West 
Africa? 
 
The history, political and socio‐cultural context of communities helps researchers to 
understand the context of actions, perspectives and expectations from research. This 
should influence the design of the clinical trials. 
 
 When research is situated in contexts where inequities are reflected through facets like 
political distrust, low research literacy and poverty, community members are at increased risk of 
a range of harmful events such as exploitation, coercion and undue inducement. Formative 
research conducted prior to study design and implementation can be used to create historical and 
socio‐cultural maps of communities. The local nuances – culture, norms, values, religion and 
practices – should be respected. Consultation participants identified the importance of local 
knowledge and local rationality. History helps one understand the rationale for what 
communities consider important. History can provide grounds for understanding the context of 
actions, perspectives and expectations from research. Experiences with disease control — 
proximity to disease, proximity to death, history of unethical trials, socio‐economic contexts of 
individuals and communities — all influence the understanding of the rationality and context for 
research in emergency situations, and attitudes towards community engagement. 
 
When is community omission (an active conscious action of exclusion) permissible in clinical 
trials conducted during infectious disease epidemics in West Africa? 
 
There is no absolute justification for community omission of in clinical trials conducted 
during infectious disease epidemics in West Africa. 
 
 It was not a task of the consultation or of this paper to provide a scan of the multitude of 
ways and forms of community engagement processes. Neither did the consultative process plan 
to map the different forms of community engagement processes during the Ebola outbreak in 
West Africa. Yet it is evident that engagement is fluid and can be expected to differ in how it is 
enacted per the context of any given emergency epidemic relative to pathogen, geography, 
culture, time, need, and a range of logistical barriers associated with community engagement 
processes. ‘Acuteness of emergency’ is an important concept here and a lower intensity of 
community engagement may be justified in research in which the risk involved is not more than 
that faced in the day to day realities of the emergency epidemic in question. In clinical trials 
however, there may be a higher requirement to include community concerns and considerations 
in the component risk/benefit analysis before making a decision on the merit of the research. 
 
 The scope of a community engagement plan may be limited when there are safety 
concerns. In a context where the disease is highly contagious, safety concerns may preclude face‐
to‐face community engagement processes. Safety concerns should however not preclude all 
forms of community engagement. Rather, community engagement related activities should use 
appropriate strategies that address the safety concerns. 
 
 Consultation participants found no absolute justification for community omission during 
an epidemic emergency. There are multiple reasons why community exclusion might happen in 
practice, however. Some of these are researcher‐driven such as lack of knowledge of engagement 
and engagement skills, inadequate funding to engage, and researchers who do not believe in the 
benefit or the moral imperative to engage. While on a case by case basis these reasons are 
arguably justifiable, they are not a priori justifications for community exclusion. While it can be 
argued that in an emergency epidemic, civil and other liberties may be suspended for the greater 
good, we argue that presumptive community omission for the benefit of the greater good can 
foster resistance and contempt for science processes; and it is a prelude for research failure. 
 
5 Discussion 
 
This study provides a timely account of how a range of community‐connected experts prioritised 
issues relating to community engagement in research during an infectious disease emergency. 
Consultation participants recognized that the objectives of community engagement during 
outbreaks may differ between researchers and communities. This may be as simple as 
researchers seeking the cooperation of community members to ensure smooth clinical trial 
implementation while community members want to ensure that communities are left better off at 
the end of the research. The use of a collaborative community engagement approach can enable 
both parties to mutually achieve their goals. The onus however rests on the researchers to 
develop a community engagement plan that is informed by the outcomes of a formative research 
that identifies ways and means by which the histories, politics and the socio‐cultural contexts of 
communities can and may influence the design and implementation of the research. In the 
context of an emergency epidemic, the implementation of a community engagement plan, 
developed in collaboration with the community (through its representatives) should be fast‐
tracked, and where possible, without compromise of the breadth and depth of the engagement 
process. Participants concurred that the omission of community engagement would not be 
acceptable for the conduct of clinical trials during an outbreak, though safety concerns may limit 
face‐to‐face community engagement activities. 
 
 One of the strengths of this research is the extensive consultation with people with a wide 
range of expertise, including ethics committee personnel, researchers, and people in the region 
who were involved with the Ebola response. The iterative consultative process with experts 
helped to validate the findings of this research. Thus, within the limits of current realities about 
how infectious disease epidemics may emerge in a region, we feel strongly that the community 
engagement model discussed may be of use to clinical researchers planning to conduct clinical 
trials during an infectious disease epidemic in West Africa. 
 
 Our study also had limitations. As previously identified by Folayan et al,33 while the use 
of the Delphi method was appropriate for reaching consensus on a complex issue with no history 
of conclusive decisions, it suffers from the possibility of some of the points of dissent and 
contention getting lost. Also, the consensus reached are based on the constructed reality of the 
experts. Our study also relied on the perspectives of expert laypersons who were members of 
ethics review committees in countries affected by Ebola and did not include the perspectives of 
general community members who were not engaged with research ethics processes. We felt 
having trained laypersons was appropriate as laypersons on ethics committee represent the 
interests of the community.34 In this capacity, they have had to handle protocols for research to 
be conducted during the epidemic, monitor such research and thus, are able to present informed 
opinions on the research questions. 
 
 Our study had considerable agreement with the ethical framework articulated in the GPP‐
EP, in that participants identified inclusivity, transparency, accountability, openness to diverse 
perspectives and paying attention to diverse vulnerability as critical underpinning values.35 
Further, participants’ identified the need to develop a community engagement plan based on 
evidence derived from the formative research, which recognises how the nuances of histories, 
economies and the socio‐cultural contexts of the community may inform research 
participation.36 This validates the proposition by the WHO on the need to conduct formative 
research prior to commencement of any research during infectious disease outbreaks. 
 
 In the interests of pragmatism, our consultation identified that while the ideal goal for any 
community engagement process is partnership and joint ownership of the research,37 a merely 
collaborative model would be acceptable during an emergency outbreak. This recognises that at 
present and in the foreseeable future, most of the clinical trials which will be conducted during 
infectious disease emergencies will be off‐shored research due to limited clinical trial capacity in 
the region. Building a full partnership model of community engagement that promotes equitable, 
collaborative decision‐making power between communities and researchers takes time and this 
may not be feasible during outbreaks. 
 
 Partnership would require that the community engagement process focuses on building 
competency and trust between trial staff and community members, and promoting equity through 
active involvement of community representatives in the design and implementation of the 
research. It is a process that recognises the differing allegiances, power dynamics, vulnerabilities 
of diverse group of stakeholders that will be impacted by the outcome of the research; and 
engaging these diverse voices in the designs and implementation of a research through an 
inclusive deliberation process. This is a time consuming process. 
 
 On the other hand, a collaborative process focuses on active engagement of the different 
stakeholders that will be impacted by the outcome of the research primarily to ensure the 
implementation of the research is conducted in an accountable and transparent process. Unlike in 
partnership where stakeholders are expected to be involved in the study design, with 
collaboration, active community engagement focused on research implementation. This proposal 
differs from the model proposed by Folayan et al.38 Like Folayan et al39 however, consultation 
participants in this study also identified other stakeholders in addition to survivors – political 
leaders, community leaders and community members ‐ that should be engaged in the consultative 
process. This research finding answers the question that begged to be answered in the manuscript 
by Folayan et al40 ‐ how should community engagement be implemented during infectious 
disease epidemics? While Folayan et al41 acknowledged the need for local investigators to lead 
off‐shored research because of their ability to negotiate the potential barriers and challenges that 
may otherwise delay research implementation, consultation participants did not raise this as a 
consideration for community engagement in research during an emergency. Future studies may 
want to specifically explore this consideration. 
 
 Our study acknowledges the limited ability to promote the goal of partnership for 
research conducted in West Africa knowing that most clinical trials are funded externally. The 
current context and climate of clinical trial practice in West Africa also makes the goal of 
partnership aspirational. We also acknowledge that as useful, equitable and value added 
community engagement is posited and found to be,42 emergency contexts are chaotic, often 
occur within social structures that are far from ideal, making even efforts at collaboration 
challenging. Researchers however, need to seek ways to overcome these challenges and conduct 
a collaborative engagement at the minimum. 
 
 Community engagement in research also needs to take place alongside other critical 
elements in infectious disease epidemic control: early case detection and diagnosis, 
comprehensive contact tracing, prompt patient isolation, supportive clinical care, and rigorous 
infection control.43 However, a community engagement plan that enhances these other infection 
control practices is feasible and important during infectious disease epidemic. Such plans should 
enhance mutual adaptation of local cultural and public health practices.44 
 
 The consensus reached with stakeholders during these consultative processes was that 
while the public health response to the epidemic will require urgent and expedited process, the 
priority should be to use available resources at the disposal of the community, nations, regions 
and international actors for public health responses to contain the spread of the infection, and 
improve survival rates. 
 
6 Conclusion 
 
This study further corroborated Miller et al's45 stance that community engagement is an ethical 
imperative for clinical trials. It is an ethical imperative for clinical trials conducted during 
infectious disease epidemic outbreaks like the recent Ebola epidemic in West Africa. Clinical 
trial research in such a context should aim to facilitate a collaborative process that both enhances 
the conduct of the clinical trial, and leaves the community better off. The community 
engagement plan developed in collaboration with community representatives should be informed 
by evidence generated from formative research that maps how the histories, politics and socio‐
cultural and economic contexts of the community will inform the community engagement 
process. Finally, despite priorities that compete in the response to an infectious disease outbreak, 
there is no presumptive justification for the exclusion of communities in the design, 
implementation and monitoring of clinical trials in West Africa. 
 
Conflict of Interest Statement 
 
No conflicts declared. 
 
Footnotes 
 
1. Miller L, Folayan MO, Allman D, et al. How Ethical is Your Clinical Trial. International 
Journal of Clinical Practice 2010; 64(9): 1179–1182. 
2. Treichler PA. How to Have Theory in an Epidemic: Cultural Chronicles of AIDS. 
Durham and London: Duke University Press, 1999. 
3. Boozary AS, Farmer PE, Jha AK, The ebola outbreak, fragile health systems, and quality 
as a cure. JAMA. 2014. 312(18):1859-1860; Richardson ET, Barrie MB, Kelly JD, Dibba 
Y, Koedoyoma S, Farmer PE. Biosocial approaches to the 2013-2016 Ebola pandemic. 
Health and Human Rights. 2016. 18(1):115-128.  
4. Calain P, Fiore N, Poncin M, Hurst SA. Research Ethics and International Epidemic 
Response: The Case of Ebola and Marburg Hemorrhagic Fevers. Public Health Ethics. 
2009. 
5. Op. Cit.  
6. World Health Organization.Good Participatory Practice for trials of emerging (and re-
emerging) pathogens that are likely to cause severe outbreaks in the near future and for 
which few or no medical countermeasures exist. 2017. Available at: 
http://www.who.int/blueprint/what/ norms-standards/GPP-EPP-December2016.pdf?ua=1 
[Accessed 2 Oct 2017]. 
7. Folayan MO, Haire B. Communitarian societies and public engagement in public health. 
Critical Public Health. https://doi.org/10.1080/09581596.2016.1252035. 
8. Ahmed SM, Palermo A-GS. Community Engagement in Research: Frameworks for 
Education and Peer Review. Am J Public Health. 2010; 100(8): 1380–1387. 
9. Center for Economic and Community Development. Why Community Engagement 
Matters. Available at: http://aese.psu.edu/research/centers/cecd/engagement-
toolbox/engagement/why-community-engagement-matters. [Accessed 2 Oct 2017]. 
10. UNAIDS/AVAC. Good participatory practice: Guidelines for biomedical HIV prevention 
trials. Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva, Second 
edition, June 2011. Available at: 
http://www.hvtn.org/content/dam/hvtn/Science/ethics/JC1853_GPP_Guidelines_2011_en
.pdf [Accessed 14 Oct 2017]. 
11. Mack N, Kirkendale S, Omullo P, et al. Implementing good participatory practice 
guidelines in the FEM-PrEP pre-exposure prophylaxis trial for HIV prevention among 
African women: a focus on local stakeholder involvement. Open Access J Clin Trials. 
2013;127. Available from: http://www.dovepress.com/implementing-good-participatory-
practice-guidelines-in-the-fem-prep-pr-peer-reviewed-article-OAJCT [Accessed 1 Oct 
2017]; Sahay S, Mehendale S. Engaging community to support HIV prevention research. 
East J Med EJM. 2011;16(2):168–77; The Ethics Working Group of the HIV Prevention 
Trials Network, MacQueen KM, Bhan A, Frohlich J, Holzer J, Sugarman J. Evaluating 
community engagement in global health research: the need for metrics. BMC Med Ethics. 
2015;16(1). Available from: http://www.biomedcentral.com/1472-6939/16/44 [Accessed 
1 Oct 2017]; Ukpong M, Clapp S, White R. Community engagement in research concept 
development: lessons from the Microbicide Trial Network. Microbicide 2008, New 
Delhi, India. 24
th
 to 27th February 2008 (Oral abstract 88). 
12. Henao-Restrepo AM, Camacho A, Longini IM, et al. Efficacy and effectiveness of an 
rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea 
ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2017; 
389: 505–518. 
13. Reuters. Update: Mali confirms new case of Ebola, locks down Bamako clinic. 12 
November 2014; World Health Organization. Ebola response roadmap – situation report. 
31 December, 2014; World Health Organization. Ebola Virus Disease – Italy.1 5 May 
2015. 
14. Richardson ET, et al. Op Cit 3. 
15. Folayan MO, Yakubu A, Haire B, Peterson K. Ebola vaccine development plan: ethics, 
concerns and proposed measures. BMC Med Ethics. 2016;17:10. 
16. National Commission for the Protection of Human Subjects of Biomedical and 
Behavioral Research. The Belmont Report: Ethical Principles and Guidelines for the 
Protection of Human Subjects of Research. Department of Health, Education and 
Welfare. 18 Apr 1979. Available at: 
https://repository.library.georgetown.edu/bitstream/handle/10822/779133/ohrp_belmont_
report.pdf?sequence=1&isAllowed=y [Accessed 14 Oct 2017]. 
17. Schröder-Bäck P, Duncan P, Sherlaw W, Brall C, Czabanowska K. Teaching seven 
principles for public health ethics: towards a curriculum for a short course on ethics in 
public health programmes. BMC Medical Ethics. 2014;15(1):73. 
18. OCHA on Message: humanitarian principles. What are humanitarian principles? 
Available at: https://www.unocha.org/sites/dms/Documents/OOM-
humanitarianprinciples_eng_June12.pdf/ [Accessed: 15 Sep 2018]. 
19. World Health Organization. Guidance for managing ethical issues during infectious 
disease outbreaks. 2016. Available at: 
http://apps.who.int/iris/bitstream/10665/250580/1/9789241549837-eng.pdf [Accessed 2 
Oct 2017]. 
20. World Health Organization. Op Cit 6. 
21. MacQueen KM, McLellan E, Metzger DS, et al. What is Community? An Evidence-
based Definition for Participatory Public Health. American Journal of Public 
Health.2001;91(12):1929–1938. 
22. Folayan MO, Haire B. Op Cit 7. 
23. Hsu C-C, Sandford BA. The Delphi Technique: Making Sense of Consensus. Practical 
Assessment, Research & Evaluation. 2007; 12(10). 
24. Allman D. Community centrality and social science research. Anthropol Med. 2015; 
22(3): 217–233. 
25. Pedi D, Gillespie A, Bedson J, et al. The Development of Standard Operating Procedures 
for Social Mobilization and Community Engagement in Sierra Leone During the West 
Africa Ebola Outbreak of 2014–2015. Journal of Health Communication 2017; 22:1, p. 
39–50., 22.https://doi.org/10.1080/10810730.2016.1212130. 
26. West-Slevin K, Ukpong M, Heise L. Community Engagement in HIV Prevention Trials: 
Evolution of the Field and Opportunities for Growth. Aids2031 Science and Technology 
Working Group, No 11, November 2008. 
27. Van Olphen J, Ottoson J, Green L, Barlow J, Koblick K, Hiatt R. Evaluation of a 
Partnership Approach to Translating Research on Breast Cancer and the Environment. 
Prog Community Health Partnersh. 2009; 3(3): 213–226. 
28. Canadian Institutes of Health Research. CIHR HIV/AIDS Community-Based Research 
Program. 2015. Available at: 
https://web.archive.org/web/20150831144112/http://www.cihr-irsc.gc.ca/e/25835.htm 
[Accessed 31 Aug 2015]. 
29. Pedi D, Gillespie A, Bedson J, et al. The Development of Standard Operating Procedures 
for Social Mobilization and Community Engagement in Sierra Leone During the West 
Africa Ebola Outbreak of 2014–2015. Journal of Health Communication 2017; 22:1, 
pp39–50., 22.https://doi.org/10.1080/10810730.2016.1212130. 
30. Storey JD, Chitnis K, Obregon R, Garrison K. Community Engagement and the 
Communication Response to Ebola. Journal of Health Communication. 201; 22: 2–4. 
31. Vergunst R, Swartz L, Mji G, Kritzinger J, Braathen SH. Beyond the checklist: 
understanding rural health vulnerability in a South African context. Global Health 
Action. 2016;9:10.https://doi.org/10.3402/gha.v9.33272. 
32. Berman A, Figueroa ME, Storey JD. Use of SMS-based surveys in the rapid response to 
the Ebola outbreak in Liberia: Opening community dialogue. Journal of Health 
Communication. 2017; 22: 15–23. 
33. Folayan MO, Haire B, Allman D, Yakubu A, Afolabi MO. Research priorities during 
infectious disease emergencies in West Africa. BMC Res Notes. 2018;11(1):159. 
34. Folayan MO, Oyedeji KS, Fatusi OA. Community members’ engagement with and 
involvement in genomic research: lessons to learn from the field. Dev World Bioeth. 
2015;15(1):1-7. 
35. World Health Organisation. Op Cit 6. 
36. Folayan MO, Haire B. History, culture and social norms: implications for Ebola drug and 
vaccine clinical trials in affected region. In: Ebola’s Message: Public Health and 
Medicine in the 21st Century. MIT Press, MA. 2016. 
37. West-Slevin K et al. Op Cit 26. 
38. Folayan MO, Haire B. Op Cit 6. 
39. Op Cit. 
40. Folayan MO, Peterson K, Kombe F. Ethics, emergencies and Ebola clinical trials: the 
role of governments and communities in offshored research. Pan Afr Med J. 2015;22 
Suppl 1:10.  
41. Op Cit. 
42. McMahon SA, Ho LS, Scott K, Brown H, Miller L, Ratayake R, Ansumana R. “We and 
the nurses are now working with one voice”: How community leaders and health 
committee members describe their role in Sierra Leone’s Ebola response. BMC Health 
Services Research. 2017; 17:495. 
43. WHO Ebola Response Team. After Ebola in West Africa — Unpredictable Risks, 
Preventable Epidemics. N Engl J Med. 2016: 375;6: 587-596. 
44. Op Cit 43. 
45. L. Miller et al. Op Cit 1. 
